Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
20.00
-0.02 (-0.10%)
Mar 24, 2026, 10:08 AM EDT - Market open
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $638.91 million as of March 24, 2026. Its market cap has increased by 567.31% in one year.
Market Cap
638.91M
Enterprise Value
487.02M
1-Year Change
567.31%
Ranking
Category
Stock Price
$20.00
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has increased from $528.69M to $638.91M, an increase of 20.85%. That is a compound annual growth rate of 9.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 639.55M | 15.65% |
| Dec 31, 2025 | 552.98M | 384.71% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gyre Therapeutics | 682.62M |
| Arvinas | 660.08M |
| Prime Medicine | 646.38M |
| Annexon | 642.43M |
| Alpha Tau Medical | 633.67M |
| Eikon Therapeutics | 632.16M |
| MiMedx Group | 629.92M |
| Design Therapeutics | 627.21M |